Profound Medical Corp Total Assets
Profound Medical Corp total assets. Based on the latest financial reports, Profound Medical Corp (PRN) holds total assets worth CA$62.28 Million CAD (≈ $45.05 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Profound Medical Corp stock valuation for the company's overall valuation and market capitalisation.
Total Assets of Profound Medical Corp (2012–2025)
Total assets of Profound Medical Corp from 2012 to 2025. This chart illustrates how Profound Medical Corp's total assets have evolved over time, based on quarterly financial data. See PRN stock price for real-time trading data and today's change.
Profound Medical Corp - Asset Composition Analysis
Profound Medical Corp Total Assets Breakdown (December 2025)
Profound Medical Corp total assets breakdown as of December 2025. Profound Medical Corp's total assets of CA$62.28 Million consist of 54.0% current assets and 46.0% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 42.4% |
| Accounts Receivable | CA$5.24 Million | 3.7% |
| Inventory | CA$8.22 Million | 5.9% |
| Property, Plant & Equipment | CA$882.00K | 0.6% |
| Intangible Assets | CA$137.75K | 0.1% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Profound Medical Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore PRN working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Profound Medical Corp's current assets represent 54.0% of total assets in 2025, a decrease from 87.8% in 2012.
- Cash Position: Cash and equivalents constituted 42.4% of total assets in 2025, up from 25.7% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 3.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 5.9% of total assets.
Profound Medical Corp Competitors by Total Assets
Key competitors of Profound Medical Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Profound Medical Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.46 | 8.53 | 24.26 |
| Quick Ratio | 5.31 | 7.07 | 22.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$49.67 Million | CA$43.09 Million | CA$83.67 Million |
Profound Medical Corp - Advanced Valuation Insights
This section examines the relationship between Profound Medical Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.98 |
| Latest Market Cap to Assets Ratio | 1.84 |
| Asset Growth Rate (YoY) | 100.2% |
| Total Assets | CA$140.62 Million |
| Market Capitalization | $258.25 Million USD |
Valuation Analysis
Above Book Valuation: The market values Profound Medical Corp's assets above their book value (1.84x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Profound Medical Corp's assets grew by 100.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Profound Medical Corp (2012–2025)
The table below shows the annual total assets of Profound Medical Corp from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CA$140.62 Million ≈ $101.72 Million |
+100.21% |
| 2024-12-31 | CA$70.23 Million ≈ $50.81 Million |
+59.95% |
| 2023-12-31 | CA$43.91 Million ≈ $31.76 Million |
-31.84% |
| 2022-12-31 | CA$64.42 Million ≈ $46.60 Million |
-25.76% |
| 2021-12-31 | CA$86.78 Million ≈ $62.77 Million |
-17.04% |
| 2020-12-31 | CA$104.60 Million ≈ $75.67 Million |
+249.97% |
| 2019-12-31 | CA$29.89 Million ≈ $21.62 Million |
-12.55% |
| 2018-12-31 | CA$34.18 Million ≈ $24.72 Million |
+54.15% |
| 2017-12-31 | CA$22.17 Million ≈ $16.04 Million |
+25.77% |
| 2016-12-31 | CA$17.63 Million ≈ $12.75 Million |
+15.44% |
| 2015-12-31 | CA$15.27 Million ≈ $11.05 Million |
+938.08% |
| 2014-12-31 | CA$1.47 Million ≈ $1.06 Million |
-42.87% |
| 2013-12-31 | CA$2.57 Million ≈ $1.86 Million |
+14.33% |
| 2012-12-31 | CA$2.25 Million ≈ $1.63 Million |
-- |
About Profound Medical Corp
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedb… Read more